DMF system initially to apply for antibiotics.

Published: 2001-12-10 06:57:00

Updated: 2001-12-10 06:57:00

Taking effects from the next year the bulk materials of antibiotics and biological preparations should be registered for use in Korea, and the bulk manufacturing company required the BGMP approval from the KFDA until the end of Dec. this year. In otherwise, the company will get punishment of the ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK